<font Color="#996633" Face="times New Roman,times,times Newroman">pfizer Disappointed In Phase Iii Study Results For 2 Drugs</font>
Source: Morning Star
Friday 12th March, 2010
The drug giant also announced two Phase III studies of its advanced breast cancer drug Sutent failed to meet their primary endpoints.
It was the latest setback for Pfizer--which already ended studies... ...
Read the full story at
Morning Star
Email this story to a friend
Have your say on this story
